MAY 24, 2017 07:30 AM PDT
Leveraging Recent Advances in Miltenyi's Cell Sorting Automation Platforms to Reduce Time to Data in Primary Cell-Based Assays.
Presented at the Lab Automation 2017 Virtual Event
SPONSORED BY: Miltenyi Biotec
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
1 1 36

Speakers:
  • Global Key Account Manager - Pharma, Miltenyi Biotec
    Biography
      Nicholas Trotter-Mayo, Ph.D., MBA, received his doctoral degree in Microbiology at the University of Virginia in 2006. After a year of post-doctoral studies at UCSD Medical Center, Dr. Trotter joined Miltenyi Biotec, Inc. as a Technical Product Scientist. He transitioned into a sales role in 2008 where he found great success and earned his MBA at the W.P. Carey School of Business at Arizona State University in 2009. Dr. Trotter has continuously progressed within the company and is currently the Global Key Account Manager for Miltenyi Biotec, Inc.

    Abstract:

    This seminar will give attendees a full overview of two new Miltenyi cell sorting platforms, the MultiMACS X and the CliniMACS Prodigy and how these instruments can be used in various primary cell assays to speed-up time to data.  These platforms offer fully automated cell sorting at throughputs and scales not previously possible using traditional sorting platforms (MACS or FACS).   We will specifically investigate how these platforms can reduce assay time in the phenotypic analysis of mouse tumor infiltrating leukocytes (TIL) and also generate sufficient numbers of primary human immune cell subsets to enable high-throughput primary cell screens.  Finally, we will introduce the MACSQuant X, a high-throughput flow cytometer, that can be leveraged in conjunction with the MultiMACS X and/or CliniMACS Prodigy to enable the rapid analysis of primary cell populations in a 384 well format.     


    Show Resources
    Loading Comments...